No sustained effects of an intervention to prevent excessive GWG on offspring fat and lean mass at 54 weeks: Yet a greater head circumference persists.


Journal

Pediatric obesity
ISSN: 2047-6310
Titre abrégé: Pediatr Obes
Pays: England
ID NLM: 101572033

Informations de publication

Date de publication:
07 2021
Historique:
received: 29 07 2020
accepted: 07 12 2020
pubmed: 5 1 2021
medline: 26 11 2021
entrez: 4 1 2021
Statut: ppublish

Résumé

LIFT (Lifestyle Intervention for Two) trial found that intervening in women with overweight and obesity through promoting healthy diet and physical activity to control gestational weight gain (GWG) resulted in neonates with greater weight, lean mass and head circumference and similar fat mass at birth. Whether these neonate outcomes are sustained at 1-year was the focus of this investigation. Measures included body composition by PEA POD air displacement plethysmography (ADP) and Echo Infant quantitative magnetic resonance (QMR) and head circumference at birth (n = 169), 14 (n = 136) and 54 weeks (n = 137). Differences in fat and lean mass between lifestyle intervention (LI) and Usual care (UC) groups were examined using ANCOVA adjusting for maternal age and BMI, GWG, offspring sex and age. Compared to UC, LI infants had similar weight (112 ± 131 g; P = .40), fat mass (14 ± 80 g; P = .86), lean mass (100 ± 63 g; P = .12) at 14 weeks and similar weight (168 ± 183 g; P = .36), fat mass (148 ± 124 g; P = .24), lean mass (117 ± 92 g; P = .21) at 54 weeks. Head circumference was greater in LI at 54 weeks (0.46 ± 2.1 cm P = .03). Greater lean mass observed at birth in LI offspring was not sustained at 14 and 54 weeks, whereas the greater head circumference in LI offspring persisted at 54 weeks.

Sections du résumé

BACKGROUND
LIFT (Lifestyle Intervention for Two) trial found that intervening in women with overweight and obesity through promoting healthy diet and physical activity to control gestational weight gain (GWG) resulted in neonates with greater weight, lean mass and head circumference and similar fat mass at birth. Whether these neonate outcomes are sustained at 1-year was the focus of this investigation.
METHODS
Measures included body composition by PEA POD air displacement plethysmography (ADP) and Echo Infant quantitative magnetic resonance (QMR) and head circumference at birth (n = 169), 14 (n = 136) and 54 weeks (n = 137). Differences in fat and lean mass between lifestyle intervention (LI) and Usual care (UC) groups were examined using ANCOVA adjusting for maternal age and BMI, GWG, offspring sex and age.
RESULTS
Compared to UC, LI infants had similar weight (112 ± 131 g; P = .40), fat mass (14 ± 80 g; P = .86), lean mass (100 ± 63 g; P = .12) at 14 weeks and similar weight (168 ± 183 g; P = .36), fat mass (148 ± 124 g; P = .24), lean mass (117 ± 92 g; P = .21) at 54 weeks. Head circumference was greater in LI at 54 weeks (0.46 ± 2.1 cm P = .03).
CONCLUSIONS
Greater lean mass observed at birth in LI offspring was not sustained at 14 and 54 weeks, whereas the greater head circumference in LI offspring persisted at 54 weeks.

Identifiants

pubmed: 33394566
doi: 10.1111/ijpo.12767
pmc: PMC8178185
mid: NIHMS1685011
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e12767

Subventions

Organisme : NICHD NIH HHS
ID : P2C HD042849
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK094416
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK094463
Pays : United States
Organisme : NIDDK NIH HHS
ID : T32 DK091227
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL114344
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK094466
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK094418
Pays : United States
Organisme : NIDDK NIH HHS
ID : T32 DK007559
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL114377
Pays : United States
Organisme : NICHD NIH HHS
ID : R00 HD086304
Pays : United States
Organisme : NICHD NIH HHS
ID : U01 HD072834
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK026687
Pays : United States

Informations de copyright

© 2021 World Obesity Federation.

Références

Arch Dis Child. 1978 Jul;53(7):606-7
pubmed: 686806
BJOG. 2010 Oct;117(11):1316-26
pubmed: 20353459
Pediatr Obes. 2016 Aug;11(4):264-71
pubmed: 26198967
Obes Rev. 2020 Aug;21(8):e13033
pubmed: 32314544
Am J Clin Nutr. 1996 Sep;64(3 Suppl):428S-435S
pubmed: 8780359
Pediatr Obes. 2012 Apr;7(2):134-42
pubmed: 22434753
Obesity (Silver Spring). 2008 Jan;16(1):191-8
pubmed: 18223634
BMC Pediatr. 2019 May 2;19(1):139
pubmed: 31046723
Proc Nutr Soc. 2007 Aug;66(3):423-34
pubmed: 17637095
Eur J Clin Nutr. 2004 Mar;58(3):541-7
pubmed: 14985694
Int J Obes (Lond). 2020 Jan;44(1):57-68
pubmed: 31292531
BMC Pediatr. 2017 Mar 27;17(1):88
pubmed: 28347278
Am J Obstet Gynecol. 2006 Oct;195(4):1100-3
pubmed: 16875645
Obes Rev. 2014 Apr;15(4):338-47
pubmed: 24321007
BMJ. 2017 Feb 8;356:j1
pubmed: 28179267
Obesity (Silver Spring). 2015 Jun;23(6):1252-8
pubmed: 25960251
J Intern Med. 2007 May;261(5):412-7
pubmed: 17444880
Obesity (Silver Spring). 2013 Jan;21(1):144-8
pubmed: 23505179
Obesity (Silver Spring). 2016 Oct;24(10):2042-9
pubmed: 27670399
J Clin Endocrinol Metab. 2014 Nov;99(11):E2367-71
pubmed: 25140402
Pediatr Res. 2017 May;81(5):825-830
pubmed: 28068308
Int J Obes Relat Metab Disord. 1999 Mar;23(3):253-9
pubmed: 10193870
Hum Biol. 1988 Oct;60(5):709-23
pubmed: 3224965
Curr Diab Rep. 2019 Jul 20;19(8):60
pubmed: 31327060
Am J Clin Nutr. 2017 Aug;106(2):491-498
pubmed: 28659299
Int J Obes (Lond). 2017 Jul;41(7):1018-1026
pubmed: 28216644
Am J Clin Nutr. 1996 Oct;64(4):650-8
pubmed: 8839517
Matern Child Nutr. 2018 Oct;14(4):e12628
pubmed: 29962095
Eur J Clin Nutr. 2015 Dec;69(12):1279-89
pubmed: 26242725
Acta Obstet Gynecol Scand. 2017 Sep;96(9):1093-1099
pubmed: 28498482
Nutr Metab (Lond). 2012 Mar 21;9:21
pubmed: 22436534
Am J Clin Nutr. 1982 May;35(5 Suppl):1169-75
pubmed: 7081099
Obesity (Silver Spring). 2018 Mar;26(3):578-587
pubmed: 29464905

Auteurs

Kathryn Whyte (K)

New York Nutrition Obesity Research Center, Division of Endocrinology, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA.

Jill Johnson (J)

New York Nutrition Obesity Research Center, Division of Endocrinology, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA.

Kim Kelly (K)

New York Nutrition Obesity Research Center, Division of Endocrinology, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA.

Michelle Horowitz (M)

New York Nutrition Obesity Research Center, Division of Endocrinology, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA.

Elizabeth M Widen (EM)

New York Nutrition Obesity Research Center, Division of Endocrinology, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA.
Institute of Human Nutrition, College of Physicians and Surgeons, Columbia University, New York, New York, USA.
Department of Nutritional Sciences, University of Texas at Austin, New York, New York, USA.

Tatiana Toro-Ramos (T)

New York Nutrition Obesity Research Center, Division of Endocrinology, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA.

Sonia Gidwani (S)

Department Pediatrics, Mount Sinai West Hospital, Mount Sinai Health System, Icahn School of Medicine, New York, New York, USA.

Charles Paley (C)

Department Pediatrics, Mount Sinai West Hospital, Mount Sinai Health System, Icahn School of Medicine, New York, New York, USA.

Janet Crane (J)

New York Nutrition Obesity Research Center, Division of Endocrinology, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA.

Susan Lin (S)

New York Nutrition Obesity Research Center, Division of Endocrinology, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA.
Center for Family and Community Medicine, Columbia University Irving Medical Center, New York, New York, USA.

Barak Rosenn (B)

Department of Obstetrics and Gynecology, Mount Sinai West Hospital, Mount Sinai Health System, Icahn School of Medicine, New York, New York, USA.

John Thornton (J)

Consultant, New York, New York, USA.

F Xavier Pi-Sunyer (FX)

New York Nutrition Obesity Research Center, Division of Endocrinology, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA.
Institute of Human Nutrition, College of Physicians and Surgeons, Columbia University, New York, New York, USA.

Dympna Gallagher (D)

New York Nutrition Obesity Research Center, Division of Endocrinology, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA.
Institute of Human Nutrition, College of Physicians and Surgeons, Columbia University, New York, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH